resiquimod has been researched along with gw 3965 in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (gw 3965) | Trials (gw 3965) | Recent Studies (post-2010) (gw 3965) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 235 | 0 | 164 |
| Protein | Taxonomy | resiquimod (IC50) | gw 3965 (IC50) |
|---|---|---|---|
| Alpha-glucosidase MAL32 | Saccharomyces cerevisiae S288C | 4.8 | |
| Oxysterols receptor LXR-beta | Homo sapiens (human) | 0.47 | |
| Oxysterols receptor LXR-alpha | Homo sapiens (human) | 0.5691 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asgarova, A; Biichlé, S; Ceroi, A; Delettre, FA; Duperrier, A; Gauthier, T; Lagrost, L; Marotel, C; Masson, D; Mourey, G; Perruche, S; Saas, P | 1 |
1 other study(ies) available for resiquimod and gw 3965
| Article | Year |
|---|---|
The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation.
Topics: Angiogenic Proteins; ATP Binding Cassette Transporter 1; Benzoates; Benzylamines; Blood Platelets; Cell-Derived Microparticles; Dendritic Cells; Endothelial Cells; Gene Expression Regulation; Humans; Hydrocarbons, Fluorinated; Hydroxycholesterols; Imidazoles; Immunity, Innate; Liver X Receptors; NF-kappa B; Oligodeoxyribonucleotides; Phenylenediamines; Primary Cell Culture; Receptors, G-Protein-Coupled; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Sulfonamides; Toll-Like Receptor 7; Tumor Necrosis Factor-alpha | 2016 |